Trouble viewing this email? View in Browser
UConn Today RSS iconFacebook iconTwitter iconYouTube iconInstagram icon

Daily HeadlinesNovember 6, 2019
Xiuling Lu, acting CEO of Nami and associate professor of pharmaceutics, talks with a graduate student who worked on the startup through a UConn program. (Submitted Photo)

Nami Therapeutics Startup Pursues Promising Drug Therapy

Nami Therapeutics, a collaboration by UConn and the University of North Carolina, is developing a tumor-specific radioactive therapy designed to specifically target ovarian cancer. Read more.
Paul Gilson, director and assistant professor of in residence of finance at the Graduate Business Learning Center in Hartford on Aug. 13, 2019. (Peter Morenus/UConn Photo)

Coveted Class: Financial Services

Since 2016, Paul Gilson also has been a faculty mentor to the Student Managed Fund, the nearly $6 million investment portfolio managed by undergraduate and graduate students. Read more.

UConn in the News

NBC

DEA Warns of Counterfeit Pills Laced With Fentanyl

American Medical Association

The 5 Skills Residency Program Directors Expect on Day One

In Social Work Podcast

UConn’s Mogro-Wilson: The Impact of Culture on the Parenting Styles of Latino Fathers

VCU News

International Symposium Explores How Nanoscience Can Help Solve Problems in Energy, Medicine

Ed Tech Magazine

Data Analytics: The Newest Tool of Aquaponic Agriculture

University Communications

University of Connecticut

34 North Eagleville Road, Unit 3144

Storrs, Connecticut 06269

communications.uconn.edu

 UConn wordmark